Under the category of the OTC/Nutraceutical products are listed the products which are sold without prescription. Members of Farmavita.net are invited to publish their out-license offers in this Category.

Description

There is on-going development of  generic EU CTD Dossier of Risedronate, tablets, 5/30/35 mg.


Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.

Risedronic acid (INN) or risedronate sodium (USAN, trade name Actonel) is a bisphosphonate used to strengthen bone, treat or prevent osteoporosis, and treat Paget's disease of bone.

More details at: http://www.rxlist.com/actonel-drug.htm.

More details

Name Description
Pharma licensing Out-licensing (offer)

Ad details

Ad ID : 41

Advertiser details

Contact Advertiser

Add comment

 
 

Contact form

Sorry, you need to register or login first.

What's wrong with this ad?

Sorry, you need to register or login first.

Add to favourites

Sorry, you need to register or login first.

Advert search

Recent adverts

A pharmaceutical company from Turkey, selling...
50 Views
Wuxi Griffin Pharmaceuticals Co. Ltd. is...
113 Views
A pharmaceutical company from Turkey, selling...
121 Views
Active substance formulated into Tivortin®  –...
157 Views
1. An entirely new combination. An original...
127 Views
I’m a representative of Parafarm (Penza,...
984 Views
Nonclinical study Tacrolimus caps. 0,5; 1,0; 5,0
856 Views